| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/22/2001 | WO2001019824A2 New active marine alkaloids |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019791A2 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments |
| 03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019371A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/α2 ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000001376A3 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385589A1 Inhibitors of factor xa |
| 03/22/2001 | CA2384656A1 New active marine alkaloids |
| 03/22/2001 | CA2382448A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 03/21/2001 | EP1084710A1 Remedies for male sterility |
| 03/21/2001 | EP1084122A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 03/21/2001 | EP1084117A2 Novel herbicides |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0681569B1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 03/21/2001 | EP0613466B1 Organic compounds |
| 03/20/2001 | US6204391 Water soluble fullerenes with antiviral activity |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/20/2001 | CA2007761C Novel benzo[b][1,8]naphtyridine derivatives and process for preparing the same |
| 03/20/2001 | CA2007760C Novel benzo[b][1,8]naphtyridine derivatives; process for preparing the same and compositions containing them |
| 03/15/2001 | WO2001018002A1 Process for production of naphthyridine-3-carboxylic acid derivatives |
| 03/15/2001 | WO2001018001A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001018000A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001017999A2 Amino-triazolopyridine derivatives |
| 03/15/2001 | WO2001017998A2 Method for the production of substituted pyrimidine derivatives |
| 03/15/2001 | WO2001017997A1 Substituted diazaanthracene compounds having pharmaceutical utility |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017979A1 Polycyclization reaction |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2001017961A2 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives |
| 03/15/2001 | WO2001017959A2 Vitronectin receptor antagonists |
| 03/15/2001 | WO2000071102A3 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 03/15/2001 | WO1999059996A8 Antitumour 1,5-diazaanthraquinones |
| 03/15/2001 | DE19943508A1 3-Vinylpyrol-Derivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel 3 Vinylpyrol derivatives, processes for their preparation and their use as medicaments |
| 03/15/2001 | DE19942809A1 Verfahren zur Herstellung substituierter Pyrimidinderivate A process for the preparation of substituted pyrimidine derivatives |
| 03/15/2001 | CA2384671A1 Vitronectin receptor antagonists |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384051A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2384048A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2383998A1 Amino-triazolopyridine derivatives |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2349451A1 Substituted diazaanthracene compounds having pharmaceutical utility |
| 03/14/2001 | EP1083176A1 Catalyzed Oxidation process for preparing quinacridone pigments uisng a polyalkylene glycol medium |
| 03/14/2001 | EP1082958A2 5-HT1F agonists in chronic pain |
| 03/14/2001 | EP1082324A1 Imidazopyridine thrombin inhibitors |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 03/14/2001 | EP0681570B1 Process for preparing quinoline amines |
| 03/14/2001 | CN1287494A preventives / remedies for glaucoma |
| 03/14/2001 | CN1287137A Oxidation process for producing quinacridineone pigment |
| 03/14/2001 | CN1063178C Aza-anthracyclinone derivatives |
| 03/13/2001 | US6201116 Halide indicators |
| 03/13/2001 | US6201016 Immunosuppressant as 5-lipoxygenase inhibitor and/or as platelet activating factor receptor antagonist |
| 03/13/2001 | US6200986 Hemoregulatory compounds |
| 03/13/2001 | US6200984 Naphtho-imidazo pyridine derivatives useful in treating central nervous system disorders |
| 03/13/2001 | US6200976 Antithrombotic quinoxazolines |
| 03/13/2001 | US6200974 For producing an anti-fibroproliferative effect |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/13/2001 | US6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases |
| 03/13/2001 | CA2033937C Hemihydrate |
| 03/08/2001 | WO2001016139A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | WO2001016133A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 03/08/2001 | WO2001016103A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | WO2001015695A1 Methods of use of fluoroquinolone compounds against bacteria |
| 03/08/2001 | WO2000076998B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/08/2001 | WO2000057870A3 Viral treatment |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | CA2383077A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | CA2381553A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | CA2378298A1 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators |
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1081136A1 Optically active tetrahydrobenzindole derivatives |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 03/07/2001 | EP1080091A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| 03/07/2001 | EP1080090A1 Antitumour 1,5-diazaanthraquinones |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1079833A1 Cocaine receptor binding ligands |
| 03/07/2001 | EP0840732B1 Substituted benzolactam compounds as substance p antagonists |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286685A Heterocyclic cytotoxic agents |
| 03/07/2001 | CN1286683A Tetrahydrobenzindole derivs |